Monte Rosa Therapeutics (GLUE) Selling, General & Administrative (2020 - 2026)
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Monte Rosa Therapeutics | 1.42 Bn | 782.73 Mn | - | 10.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.13 Mn |
| Mar 31, 2026 | 10.18 Mn |
| Dec 31, 2025 | 10.52 Mn |
| Sep 30, 2025 | 9.07 Mn |
| Jun 30, 2025 | 8.10 Mn |
| Mar 31, 2025 | 8.70 Mn |
| Dec 31, 2024 | 8.78 Mn |
| Sep 30, 2024 | 8.13 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 8.99 Mn |
| Dec 31, 2023 | 7.73 Mn |
| Sep 30, 2023 | 8.66 Mn |
| Jun 30, 2023 | 8.15 Mn |
| Mar 31, 2023 | 7.50 Mn |
| Dec 31, 2022 | 7.62 Mn |
| Sep 30, 2022 | 7.02 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | 6.39 Mn |
| Dec 31, 2021 | 5.26 Mn |
| Sep 30, 2021 | 4.75 Mn |